Trial intelligence / Profile preview

SMOFlipid vs Lipovenoes MCT in Post-Gastrectomy Patients

NCT00885781Phase 4Completed

Sponsor
National Taiwan University Hospital
Start
Nov 2008
Primary completion
Apr 2009
Modality
Lipid-based Nanoparticles
Countries
1
01

Overview

Phase 4, randomised trial of SMOFlipid in Malnutrition (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Evidence for immunoregulatory effect of lipid emulsion products. Started Nov 2008; status: completed.

02

Drugs

SMOFlipid
03

Conditions

Malnutrition

Beyond the preview

Go deeper on NCT00885781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00885781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call